— Know what they know.
Not Investment Advice

VASO OTC

Vaso Corporation
1W: +0.3% 1M: +2.0% 3M: +55.8% YTD: +73.8% 1Y: +153.9% 3Y: -10.3% 5Y: +491.9%
$0.30
+0.00 (+1.70%)
 
Weekly Expected Move ±6.7%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Neutral · Power 62 · $52.1M mcap · 99M float · 0.152% daily turnover · Short 21% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$52.1M
52W Range0.105-0.34
Volume5,100
Avg Volume150,329
Beta0.70
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJun Ma
Employees282
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date1995-08-18
137 Commercial Street
Plainview, NY 11803
US
516 997 4600
About Vaso Corporation

Vaso Corporation is a diversified enterprise engaged in both the healthcare equipment and information technology industries, serving markets within the United States and globally. The company's operations are structured across three primary divisions: 1. IT (Information Technology): This segment is dedicated to providing specialized IT solutions for the healthcare sector, alongside managed network technology services. Its services encompass managed diagnostic imaging applications, network infrastructure management, network transport, and comprehensive cybersecurity solutions. 2. Professional Sales Service: This division primarily focuses on the distribution of capital medical equipment manufactured by General Electric Healthcare (GEHC) to mid-sized healthcare providers. Its offerings include GEHC diagnostic imaging hardware, associated service contracts, training programs, and financial services facilitated by both GEHC and external partners. 3. Equipment: This segment concentrates on the development, manufacturing, sales, and servicing of its own proprietary medical devices. Its product portfolio features the Biox series, which includes Holter monitors and ambulatory blood pressure recorders; the ARCS series software for analyzing, reporting, and communicating ECG and blood pressure data; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation (EECP) therapy systems, used for non-invasive, outpatient treatment of ischemic heart disease. Founded in 1987, the company was originally named Vasomedical, Inc. before officially rebranding as Vaso Corporation in November 2016. Vaso Corporation maintains its corporate headquarters in Plainview, New York.

Recent Insider Trades

NameTypeSharesPriceDate
McMeans Shaun D 0 — 2026-07-23
Ma Jun P-Purchase 200,000 $0.13 2024-11-21
Dembo Leon A-Award 150,000 — 2024-11-15
Markowitz Joshua J-Other 55,738,318 — 2023-04-17
Dembo Leon 0 — 2023-04-03

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms